ArticleJournal of neuroinflammation2022

A selective inhibitor of the NLRP3 inflammasome as a potential therapeutic approach for neuroprotection in a transgenic mouse model of Huntington's disease.

Kai-Po Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.